Abstract
The adopted UK-wide regulatory act legitimating technologies of so-called mitochondrial donations for the production of human embryos – entitled the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations, 2015, No. 5721 (which shall come into force on October 29, 2015) – will create a lot of new risks and raise specific new bioethical and legal questions and problems. These questions also become relevant for Russia, given the fact that, first, the administration of the Ministry of Health of the Russian Federation tends on liberal line to underestimate and disregard the rules of bioethics when making many, if not most, decisions in the area of health protection and, second, it is anticipated that in the near future Russian ‘innovators’ will try to adopt and slavishly borrow whatever might be of a commercial interest, disregarding ethical issues.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
